Prolonged survival times of allogeneic skin grafts using somatic cell hybrids.
D000818:Animals; D000918:Antibody Specificity; D003602:Cytotoxicity, Immunologic; D006085:Graft Survival; D006183:H-2 Antigens; D006822:Hybrid Cells / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods*; D007518:Isoantibodies; D051379:Mice; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D006183:H-2 Antigens; D007518:Isoantibodies